GGrantIndex
← Leaderboards

Hollie Isabel Swanson

University Of Kentucky

$5,278,307
Attributed
$5,417,884
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,417,884 · 6

By mechanism

R01$4,393,537 · 3
R25$769,409 · 1
R03$143,847 · 1
R29$111,091 · 1

Top collaborators

Most similar at University Of Kentucky

Same institution · by research overlap

Others in their field

Top investigators on “Dioxins

Research focus

DioxinsPlayDesignLaboratoriesTechnologyEvaluationEthicsExperimental StudyAreaAppalachian RegionEconomicsElevatorAromatic Hydrocarbon ReceptorEducational WorkshopFacultyCollegeApoptosisEnvironmentCommunitiesCarcinogenesisAffectCritical ThinkingCareerEngineering

Grant awards (27)

Summer Research in Environmental Health Sciences$9,154
R25 · FY2025 · ES · contact PI
Summer Research in Environmental Health Sciences$135,000
R25 · FY2024 · ES · contact PI
Summer Research in Environmental Health Sciences$135,000
R25 · FY2023 · ES · contact PI
Summer Research in Environmental Health Sciences$98,051
R25 · FY2022 · ES · contact PI
Summer Research in Environmental Health Sciences$98,051
R25 · FY2020 · ES · contact PI
Summer Research in Environmental Health Sciences$98,051
R25 · FY2019 · ES · contact PI
Summer Research in Environmental Health Sciences$98,051
R25 · FY2018 · ES · contact PI
Summer Research in Environmental Health Sciences$98,051
R25 · FY2017 · ES · contact PI
AHR-Protac, a novel aryl hydrocarbon receptor antagonist$257,529
R01 · FY2010 · ES · contact PI
AHR-Protac, a novel aryl hydrocarbon receptor antagonist$260,130
R01 · FY2009 · ES · contact PI
AHR-Protac, a novel aryl hydrocarbon receptor antagonist$260,130
R01 · FY2008 · ES · contact PI
AHR-Protac, a novel aryl hydrocarbon receptor antagonist$265,954
R01 · FY2007 · ES · contact PI
Chemopreventive properties of aryl hydrocarbon receptor antagonists$70,853
R03 · FY2007 · CA · contact PI
Convergence of TCDD Gene Activation with Other Pathways$391,875
R01 · FY2006 · ES · contact PI
Dioxin and Keratinocyte Differentiation$282,794
R01 · FY2006 · ES · contact PI
AHR-Protac, a novel aryl hydrocarbon receptor antagonist$274,374
R01 · FY2006 · ES · contact PI
Chemopreventive properties of aryl hydrocarbon receptor antagonists$72,994
R03 · FY2006 · CA · contact PI
Convergence of TCDD Gene Activation with Other Pathways$70,151
R01 · FY2006 · ES · contact PI
Dioxin and Keratinocyte Differentiation$289,600
R01 · FY2005 · ES
Convergence of TCDD Gene Activation with Other Pathways$289,600
R01 · FY2005 · ES
Dioxin and Keratinocyte Differentiation$289,600
R01 · FY2004 · ES
Convergence of TCDD Gene Activation with Other Pathways$289,600
R01 · FY2004 · ES
Convergence of TCDD Gene Activation with Other Pathways$289,600
R01 · FY2003 · ES
Dioxin and Keratinocyte Differentiation$284,000
R01 · FY2003 · ES
Convergence of TCDD Gene Activation with Other Pathways$314,600
R01 · FY2002 · ES
Dioxin and Keratinocyte Differentiation$284,000
R01 · FY2002 · ES
CONVERGENCE OF TCDD GENE ACTIVATION WITH OTHER PATHWAYS$111,091
R29 · FY2000 · ES